These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 8583314

  • 1. Preparation and characterization of niosomes containing rifampicin for lung targeting.
    Jain CP, Vyas SP.
    J Microencapsul; 1995; 12(4):401-7. PubMed ID: 8583314
    [Abstract] [Full Text] [Related]

  • 2. Prolonged release biodegradable vesicular carriers for rifampicin--formulation and kinetics of release.
    Kamath MP, Shenoy BD, Tiwari SB, Karki R, Udupa N, Kotian M.
    Indian J Exp Biol; 2000 Feb; 38(2):113-8. PubMed ID: 11218826
    [Abstract] [Full Text] [Related]

  • 3. Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization.
    Abdelkader H, Ismail S, Kamal A, Alany RG.
    Pharmazie; 2010 Nov; 65(11):811-7. PubMed ID: 21155387
    [Abstract] [Full Text] [Related]

  • 4. Preparation and characterization of EP-liposomes and Span 40-niosomes.
    Ning M, Guo Y, Pan H, Zong S, Gu Z.
    Pharmazie; 2006 Mar; 61(3):208-12. PubMed ID: 16599261
    [Abstract] [Full Text] [Related]

  • 5. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
    Guinedi AS, Mortada ND, Mansour S, Hathout RM.
    Int J Pharm; 2005 Dec 08; 306(1-2):71-82. PubMed ID: 16263229
    [Abstract] [Full Text] [Related]

  • 6. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
    Mokhtar M, Sammour OA, Hammad MA, Megrab NA.
    Int J Pharm; 2008 Sep 01; 361(1-2):104-11. PubMed ID: 18577437
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and application of poly(ethylene glycol)-cholesterol (Chol-PEGm) conjugates in physicochemical characterization of nonionic surfactant vesicles.
    Yang DB, Zhu JB, Huang ZJ, Ren HX, Zheng ZJ.
    Colloids Surf B Biointerfaces; 2008 Jun 01; 63(2):192-9. PubMed ID: 18295461
    [Abstract] [Full Text] [Related]

  • 8. Localized rifampicin albumin microspheres.
    Pande S, Vyas SP, Dixit VK.
    J Microencapsul; 1991 Jun 01; 8(1):87-93. PubMed ID: 1880695
    [Abstract] [Full Text] [Related]

  • 9. [Studies on the preparation of camptothecin niosomes].
    Luan LB, Zhu JB, Yu WP, Wei KB.
    Yao Xue Xue Bao; 2002 Jan 01; 37(1):59-62. PubMed ID: 12579902
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.
    Paolino D, Muzzalupo R, Ricciardi A, Celia C, Picci N, Fresta M.
    Biomed Microdevices; 2007 Aug 01; 9(4):421-33. PubMed ID: 17252206
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic study of niosome encapsulated insulin.
    Khaksa G, D'Souza R, Lewis S, Udupa N.
    Indian J Exp Biol; 2000 Sep 01; 38(9):901-5. PubMed ID: 12561948
    [Abstract] [Full Text] [Related]

  • 12. Preparation and characterization of niosomes containing ribavirin for liver targeting.
    Hashim F, El-Ridy M, Nasr M, Abdallah Y.
    Drug Deliv; 2010 Jul 01; 17(5):282-7. PubMed ID: 20350052
    [Abstract] [Full Text] [Related]

  • 13. Preparation and characterization of 5-fluorouracil pH-sensitive niosome and its tumor-targeted evaluation: in vitro and in vivo.
    Wang M, Yuan Y, Gao Y, Ma HM, Xu HT, Zhang XN, Pan WS.
    Drug Dev Ind Pharm; 2012 Sep 01; 38(9):1134-41. PubMed ID: 22182601
    [Abstract] [Full Text] [Related]

  • 14. Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B.
    Vyas SP, Singh RP, Jain S, Mishra V, Mahor S, Singh P, Gupta PN, Rawat A, Dubey P.
    Int J Pharm; 2005 May 30; 296(1-2):80-6. PubMed ID: 15885458
    [Abstract] [Full Text] [Related]

  • 15. Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol.
    Devaraj GN, Parakh SR, Devraj R, Apte SS, Rao BR, Rambhau D.
    J Colloid Interface Sci; 2002 Jul 15; 251(2):360-5. PubMed ID: 16290741
    [Abstract] [Full Text] [Related]

  • 16. Niosomal encapsulation of the antitubercular drug, pyrazinamide.
    El-Ridy MS, Abdelbary A, Nasr EA, Khalil RM, Mostafa DM, El-Batal AI, Abd El-Alim SH.
    Drug Dev Ind Pharm; 2011 Sep 15; 37(9):1110-8. PubMed ID: 21417612
    [Abstract] [Full Text] [Related]

  • 17. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium.
    Manosroi A, Jantrawut P, Manosroi J.
    Int J Pharm; 2008 Aug 06; 360(1-2):156-63. PubMed ID: 18539416
    [Abstract] [Full Text] [Related]

  • 18. Formulation of Tyloxapol niosomes for encapsulation, stabilization and dissolution of anti-tubercular drugs.
    Mehta SK, Jindal N.
    Colloids Surf B Biointerfaces; 2013 Jan 01; 101():434-41. PubMed ID: 23010052
    [Abstract] [Full Text] [Related]

  • 19. Stability of luciferase plasmid entrapped in cationic bilayer vesicles.
    Manosroi A, Thathang K, Werner RG, Schubert R, Manosroi J.
    Int J Pharm; 2008 May 22; 356(1-2):291-9. PubMed ID: 18281170
    [Abstract] [Full Text] [Related]

  • 20. Preparation of curcuminoid niosomes for enhancement of skin permeation.
    Rungphanichkul N, Nimmannit U, Muangsiri W, Rojsitthisak P.
    Pharmazie; 2011 Aug 22; 66(8):570-5. PubMed ID: 21901978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.